Paper56397
Modulation of help and suppression in a hapten-carrier system.
Eardley DD and 1 other. J Immunol, 1976. Cited by 32 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Download JSON
Cite this record
ConductScience Library. Modulation of help and suppression in a hapten-carrier system. Papers, record 56397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/56397
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carrier Proteins | Major topic |
| Haptens | Major topic |
| Immunization | Major topic |
| Immunosuppression Therapy | Major topic |
| Animals | |
| Epitopes | |
| Galactosidases | |
| Hemolytic Plaque Technique | |
| Immunization, Passive | |
| Mice | |
| Mice, Inbred CBA | |
| Nitrobenzenes | |
| T-Lymphocytes | |
| Time Factors |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,777,033 | Philosophical and distinct SLE epitomes: dogmas in conflict with evidences and an intellectual dissonance between established pathophysiological models. | Front Immunol | 2025 | https://conductscience.org/library/papers/40777033 | PubMed |
| 39,936,150 | Why is it so difficult to understand why we don't understand human systemic lupus erythematosus? Contemplating facts, conflicts, and impact of "the causality cascade paradigm". | Front Immunol | 2024 | https://conductscience.org/library/papers/39936150 | PubMed |
| 38,895,113 | SLE: a cognitive step forward-a synthesis of rethinking theories, causality, and ignored DNA structures. | Front Immunol | 2024 | https://conductscience.org/library/papers/38895113 | PubMed |
| 35,087,528 | The Anti-DNA Antibodies: Their Specificities for Unique DNA Structures and Their Unresolved Clinical Impact-A System Criticism and a Hypothesis. | Front Immunol | 2021 | https://conductscience.org/library/papers/35087528 | PubMed |
| 6,168,025 | Function of macrophages as antigen presenting cells. | Springer Semin Immunopathol | 1980 | https://conductscience.org/library/papers/6168025 | PubMed |
| 324,904 | B-memory cells can be stimulated by antigen in vitro to become IgG antibody-secreting cells. | Immunology | 1977 | https://conductscience.org/library/papers/324904 | PubMed |
| 306,409 | Effect of colchicine on the antibody response. II. Demonstration of the inactivation of suppressor cell activities by colchicine. | J Exp Med | 1978 | https://conductscience.org/library/papers/306409 | PubMed |
| 302,306 | Separation of helper and suppressor T lymphocytes. II. Ly phenotypes and lack of DNA synthesis requirement for the generation of concanavalin A helper and suppressor cells. | J Exp Med | 1977 | https://conductscience.org/library/papers/302306 | PubMed |
| 200,320 | Effect of age and pregnancy on the antibody and cell-mediated immune responses of horses to equine herpesvirus 1. | Can J Comp Med | 1977 | https://conductscience.org/library/papers/200320 | PubMed |
| 77,305 | Effect of colchicine on the antibody response. I. Enhancement of antibody formation in mice. | J Exp Med | 1978 | https://conductscience.org/library/papers/77305 | PubMed |
| 71,736 | Key antigenic determinants in regulation of the immune response. | Proc Natl Acad Sci U S A | 1977 | https://conductscience.org/library/papers/71736 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/56397
GET https://conductscience.org/api/papers/v1/56397/authors